request Request a Protocol
ask Ask a question
Favorite

RBL-2H3 cells (1 × 106 cells/well) were seeded in 24-well plates and treated with 200 ng/mL of DNP-specific IgE (Sigma-Aldrich, St. Louis, MO, USA). Cells were treated with or without GBR, GBR-SC61, GBR-SP024 (200 μg/mL), or PP2 (Calbiochem, La Jolla, CA, USA) which is an Src tyrosine kinase inhibitor. After incubation for 30 min at 37 °C, the cells were exposed to 200 ng/mL of DNP-BSA antigen (Sigma-Aldrich) for 15 min at 37 °C. The degree of degranulation was determined by measuring the amount of β-hexosaminidase released, as previously described [13]. The absorbance at 405 nm was measured using a microplate reader (Epoch).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A